The COVID-19 pandemic led to an intense search for products that could help control the spread of that and other viruses, making the need for testing virucidal efficacy increase hundredfold. Products with current virucidal claims scrambled to secure a SARS-CoV-2 claim, while new products vied for the chance to be the "next new thing" that could hel...